Cytokinetics
CYTK
CYTK
347 hedge funds and large institutions have $9.74B invested in Cytokinetics in 2023 Q4 according to their latest regulatory filings, with 122 funds opening new positions, 74 increasing their positions, 109 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
39% more funds holding
Funds holding: 250 → 347 (+97)
5.18% more ownership
Funds ownership: 113.83% → 119.02% (+5.2%)
32% less repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 109
Holders
347
Holding in Top 10
20
Calls
$1.4B
Puts
$787M
Top Buyers
| 1 | +$136M | |
| 2 | +$80.8M | |
| 3 | +$38.6M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$36.8M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$36.5M |
Top Sellers
| 1 | -$54.2M | |
| 2 | -$45.6M | |
| 3 | -$44.8M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$34.7M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$32.9M |